Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Primary hepatic carcinoma treating pill

A technology of pills for primary liver cancer, applied in the field of pills for the treatment of primary liver cancer, can solve the problems of lack, high cost, and side effects of Western medicine, and achieve the effects of prolonging survival, less toxic side effects, and regulating the body's immunity

Inactive Publication Date: 2017-10-17
刘进池
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In drug treatment, western medicine has many side effects and is expensive, while traditional Chinese medicine has few side effects and relatively low cost in treating liver cancer, but there is a shortage of such traditional Chinese medicine with good curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] The present invention will be further elaborated below in conjunction with embodiment.

[0009] The pill for treating primary liver cancer is made of the following raw materials in parts by weight: 15-25 parts of sheep's trotters, 6-10 parts of vinegar trigonum, 6-10 parts of capillary, 15-25 parts of Scutellaria barbata, 6- 10 parts, Shandougen 15-25 parts, Eclipta 15-25 parts, Moutan bark 6-10 parts, Miltonia 15-25 parts, Codonopsis 16-22 parts, Astragalus 20-25 parts, Ziheche 14 parts -16 parts, 14-16 parts of white peony, 14-16 parts of medlar, 16-22 parts of Bupleurum, 16-22 parts of bergamot, 12-18 parts of milk thistle, 14-16 parts of desmodium, 14- 16 parts, 8-12 parts of Atractylodes macrocephala, 14-16 parts of Citrus aurantium, 16-22 parts of Angelica sinensis, 16-22 parts of Corydalis Corydalis, 14-16 parts of safflower, 9-11 parts of Salvia miltiorrhiza, 14-16 parts of turtle shell, and white snake Tongue grass 14-16 parts, Prunella vulgaris 14-16 parts, D...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a primary hepatic carcinoma treating pill. The primary hepatic carcinoma treating pill is prepared from, by weight part, 15-25 parts of rumex japonicas, 6-10 parts of rhizoma sparganic with vinegar, 6-10 parts of capillary artemisia, 15-25 parts of sculellaria barbata, 6-10 parts of polyporus umbellatus, 15-25 parts of subprostrate sophora, 15-25 parts of eclipta, 6-10 parts of coxtex moutan, 15-25 parts of caulis spatholobi, 16-22 parts of codonopsis pilosula, 20-25 parts of astragalus membraneceus, 14-16 parts of placenta hominis, 14-16 parts of radix paeoniae alba, 14-16 parts of lycium barbabrum, 16-22 parts of radix bupleuri, 16-22 parts of citrus chirocarpus, 12-18 parts of silybum marianum, 14-16 parts of lysimachia christinae hance, 14-16 parts of corn stigma, 8-12 parts of rhizoma atractylodis macrocephalae, 14-16 parts of fructus aurantii, 16-22 parts of angelica sinensis, 16-22 parts of corydalis tuber, 14-16 parts of red flower, 9-11 parts of salvia miltiorrhiza, 14-16 parts of turtle shell, 14-16 parts of oldenlandia diffusa, 14-16 parts of selfheal, 14-16 parts of dandelion, 9-11 parts of Iphigenia indica, 9-11 parts of green tangerine peel, 6-8 parts of kelp, 4-6 parts of myrrh and 3-5 parts of liquorice. The primary hepatic carcinoma treating pill is prepared from pure Chinese herbs, thereby being low in side and toxic effects and capable of regulating immunity, inhibiting growth of cancer cells, inducing apoptosis and differentiation of the cancer cells, interfering biosynthesis of the cancer cells and inhibiting metastasis and recurrence of liver cancer to achieve the aim of preventing and controlling liver cancer.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a pill for treating primary liver cancer. Background technique [0002] Liver cancer is a malignant tumor that occurs in the liver. There are two types: primary and secondary. Primary liver cancer originates from the epithelial or mesenchymal tissue of the liver. At present, the treatment methods for liver cancer mainly include surgery, radiotherapy, chemotherapy and drugs. Surgery is very harmful to the human body, while radiotherapy and chemotherapy can not only kill cancer cells, but also cause damage to normal human cells. In drug treatment, western medicine has many side effects and is expensive, while traditional Chinese medicine has few side effects and relatively low cost for treating liver cancer, but there is a lack of such traditional Chinese medicine with good curative effect. Contents of the invention [0003] The purpose of the invention is to overc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/902A61K9/20A61P35/00A61K35/586A61K35/50
CPCA61K9/2068A61K35/50A61K35/586A61K36/03A61K36/07A61K36/185A61K36/232A61K36/233A61K36/28A61K36/282A61K36/284A61K36/286A61K36/288A61K36/328A61K36/344A61K36/481A61K36/484A61K36/486A61K36/489A61K36/53A61K36/536A61K36/537A61K36/539A61K36/65A61K36/66A61K36/70A61K36/71A61K36/748A61K36/752A61K36/815A61K36/898A61K36/899A61K36/902A61K2300/00
Inventor 刘进池
Owner 刘进池
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products